Back to announcement
20250430_LABS_Laporan Informasi dan Fakta Material_31881010_lamp1.pdf
Financial statement Text extracted LABSSource file signed link, expires in 15 minutes
Extracted text 3
Page 1 OCR 0.850
UBC Medical Indonesia Tbk PT UBC MEDICAL INDONESIA Tbk dan Entitas Anak LAPORAN POSISI KEUANGAN KONSOLIDASIAN Per 31 Maret 2025 dan 2024 (Disajikan dalam Rupiah, kecuali dinyatakan lain) 31 Maret 2025 March 31, 2025 PT UBC MEDICAL INDONESIA Tbk and Subsidiary CONSOLIDATED STATEMENT OF FINANCIAL POSITION 31 Desember 2024 December31, 2024 Catatar/ Note ASET Aset Lancar Kas dan setara kas 2c,20,21,2h,4,34,35 Piutang usaha Pihak ketiga 24,29,5,35 Pihak berelasi 20,29,21,5,332,35 Persediaan 26 Pajak dibayar dimuka 2u,14a Biaya dibayar dimuka 27 Uang muka 27 Jumlah Aset Lancar Aset Tidak Lanc: Piutang laindain 298 Aset tetap -bersih 20,36 Aset hak guna usaha 2913 Aset pajak tangguhan - bersih 2,tad Beban ditangguhkan 2m,10,35 Aset takberwujud 2n,11,35 Aset lsin-ain tidak lancar 12 Jumlah Aset Tidak Lancar JUMLAH ASET Catatan atas laporan keuangan merupakan bagian yang tidak terpisahkan dari laporan keuangan Head Office : Kawasan Industri Pulogadung Jl. Rawa Gelam V, Blok. L, Kav!1-13 Gedung Etana 3FI, Jakarta 13930 29.071.372.895 42.553.641.574 0.855.982.644 19.455.426.581 2 129.530.972 78.503.545.817 71.852.237.955 18.771.759.035 15.663.749.576 1.636.061.959 545.293.071 12.493.870.966 8.845.327.937 171.332.503.316 159.045.207.666 160.000.000 337.522.420 30.079.301.436 33.134.725.636 316.913.699 316.913.699 2.897.178.900 2.897.178.901 2.107.425.951 2.489.365.741 5.024.955.356 5.339.326.978 39.080.970 39.080.970 40.624.946.313 44.554114.345 211.957.539.629 203.599.322.011 Jakarta, 30 April/ April 30, 2025 Eranciscus Xaverii Direktur Utama/ President Director -1a- W “ Marcelia Angelin Direktur/ Director 'AAs of March 31, 2025 and 2024 (Expressed in Rupiah, unless otherwise stated) 'ASSETS Current Assets Cash and cash eguivalents Account recoivables - nett Third parties Related parties Inventories Prepaid tax Prepaid expense Advance payment Total Current Assets Non Current Assets Other receivables Fixes assets - nett Right of use assets (Deferred tax assets - nett Deferred charges Intangible assets Other non current assets Total Non Current Assets TOTAL ASSETS The accompanying notes from an intogral part of these financial statemonts Contact Us: (021) 3886s110 Infoube@ubcindonesia.com wwubcindonesia.corn
Page 2 OCR 0.844
UBC Medical Indonesia Tbk PT UBC MEDICAL INDONESIA Tbk dan Entitas Anak PT UBC MEDICAL INDONESIA Tbk and Subsidiary LAPORAN POSISI KEUANGAN KONSOLIDASIAN Per 31 Maret 2025 dan 2024 (Disajikan dalam Rupiah, kecuali dinyatakan lain) Catatar/ 31 Maret 2025 31 Desember 2024 Note March 31, 2025 December31, 2024 LIABILITAS DAN EKUITAS LIABILITAS Liabilitas Jangka Pendek Utang bank 2a21 24.789.536.334 23.872.569.303 Utang usaha Pihak ketiga 2e,2h,21,2p15,34,35 32.160.240.560 26.419.326.108 Pihak berelasi 2e,2i,29,15,33b,34,35 148.000.695 43.893.597 Utang laindain Pihak ketiga 2i,2p,16,33,34 o - Utang pajak 2t,14b 1.355.919.816 312.000.702 Uang muka pelanggan 2s17 10.756.589 6.967.588 Beban masih harus dibayar 21,18,34,35 309.271.554 586.483.989 Liablitas jangka panjang yang akan jatuh tempo dalam satu tahun: Utang pembiayaan konsumen 29,19,34,35,36 167.313.239 1.029.397.320 Utang sewa hak guna 29,20,34,35 191.803.090 252.710.663 Uang muka setoran modal 22 - - Jumlah Liabilitas Jangka Pendek 29-132841.876 52623349270 Liabilitas Jangka Panjang Utang jangka panjang-setelah dikurangi bagian yang jatuh tempo kurang dari satu tahun : Utang pembiayaan konsumen 29,19,34,35,36 1.715.201.131 1.715.201.131 Utang sewa hak guna 29,20,34,35 89.809.787 89.809.787 Utang pihak berelasi 21,33c 8.881.468.276 8.881.468.277 Liabiltas imbalan kerja 20,23 1.534.852.922 1.534.852.922 Jumlah Liabilitas Jangka Panjang 12.221.332A17 12221332417 JUMLAH LIABILITAS 71.354 173993 SA.B7A.681.387 EKUITAS Modal saham - nilai nominal Rp20 dan Rp40 pada 31 Desember 2024 dan 2023 Modal dasar sebesar sebesar 3.950.000.000 dan 3.512.482.000 lembar saham pada 31 Desember 2024 dan 2023 Modal ditempatkan dan disetor penuh sebesar 3.950.000.000 dan 1.625.000.000 per 31 Desember 2024 dan 2023 24 79.000.000.000 79.000.000.000 Tambahan modal disetor 25 54.157.308.467 54.157.308.467 Selisih kurs modal disetor 537.250.000 537.250.000 Saldo laba Telah ditentukan penggunaannya 26 400.000.000 400.000.000 Belum ditentukan penggunaannya 26 6.670.171.357 4.821.461.533 Penghasilan komprehensif lain (161.477.373 161.477.373) 740.603.252.451 T38.754.542.627 Kepentingan non-pengendali 113185 97.007 JUMLAH EKUITAS 140.603.365.636 T3B.754-640.624 JUMLAH LIABILITAS DAN EKUITAS 211.957.539.628 203.599.322.011 Jakarta, 30 April/ April 30, 2025 2 v Eranciscus Xaverius Yoshua Raintjung M Angelin Direktur Utama/ President Director Direktur! Director Catatan atas laporan keuangan merupakan lbagian yang tidak terpisahkan dari laporan keuangan -1b- Head Office : Kawasan Industri Pulogadung JI. Rawa Gelam V, Blok. L, Kav!!l-13 Gedung Etana 3FI, Jakarta -13930 STATEMENT OF FINANCIAL POSITION As of March 31, 2025 and 2024 (Expressed in Rupiah, unless olherwise stated) 816.967.031 LIABILITIES AND E@UITY LIABILITIES Current Liabilities Loans Payable Account payables Third parties Related parties Other Payable Third parties Taxes payable 'Advances from customers 'Accrued expenses Current maturity of long Zerm liabilities: Consumer finance payable Lease Ilabilities “Advance paid in capital Total Current Liabilities Long Term Liabilities Long term liabiliies - net of Current maturities Consumer finance payable Lease liabilties Due to related parties Employee benefit iabilities Total Long Term Liabilities TOTAL LIABILITIES EGUITY Capital stock - par value Rp20 and Rp40 in December 31, 2024 and 2023 Authorized Capital 3,950,000,000 and 3,512,482,000 shares in December 31, 2024, and 2023 Issued and fully paid up capital 3,950,000,000 and 1,625,000,000 December 31, 2024 and 2023 Additional paid in capital Foreign exchange diffrence in paid - up capital Retained eamings Appropriated Unappropriated Other comprehensive income Non-controlling interests TOTAL EGUITY TOTAL LIABILITIES AND EGUITY The accompanying notes from an integral part of these financial statements Contact Us: (o21 388es1o ndonesia.com
Page 3 OCR 0.856
UBC Medical Indonesia Tbk PT UBC MEDICAL INDONESIA Tbk dan Entitas Anak LAPORAN LABA RUGI DAN PENGHASILAN KOMPREHENSIF LAIN KONSOLIDASIAN Untuk Tahun Yang Berakhir Pada Tanggal 31 Maret 2025 dan 2024 (Disajikan dalam Rupiah, kecuali dinyatakan lain) PT UBC MEDICAL INDONESIA Tbk and Subsidiary CONSOLIDATED STATEMENT OF PROFIT OR LOSS (AND OTHER COMPREHENSIVE INCOME For The Years Ended March 31, 2025 and 2024 (Expressed in Rupiah, unless otherwise stated) Catatan/ 31 Maret 2025 31 Maret 2024 Note March 31, 2025 March 31, 2024 PENDAPATAN 25,2x,27,334,37 33462.750.531 28.742.427.381 'REVENUE BEBAN POKOK PENDAPATAN 25,2x,28,37 (18.143.156.199) (14:366.938.470) COST OF REVENUE LABA BRUTO 15.319.594332 14375488.912 GROSS PROFIT BEBAN OPERASIONAL OPERATING EXPENSES Beban penjualan dan pemasaran 25,29,37 5.081.023.214 5.629.867.330 Selling and marketing Beban umum dan adminstrasi 25,30,37 7.144.763.389 7.308.181.010 General and administrative JUMLAH BEBAN OPERASIONAL 12.225.786.602 T2.938.048.340 TOTAL OPERATING EXPENSES LABA USAHA 3.093.807.730 TA37 140572 OPERATING PROFIT PENDAPATAN (BEBAN) LAIN-LAIN OTHER INCOME (EXPENSES) Laba pelepasan penyertaan Gain on disposal in @entitas asosiasi 2s,31,37 - associate companies Laba penjualan aset 2s,31,37 - Gain on sale of Ixed assets Pendapatan keuangan 25,31,37 39.791.305 1.822.068 Finance income Biaya keuangan 2s,31,33e,37 (384.226.802) (641.384.864) Finance cost Laba (rugi) selisih kurs 25,31,37 (903.057.767) (330.272.011) (Loss) gain of foreign exchange Beban cadangan penyisihan 'Allowance for impairment losses of persediaan 25,31,37 - inventories Pemulihan (penyisihan) Recovery (allowance) for impairment penurunan nilai piutang 2s,31,37 - of account receivables Pendapatan (beban) lain-ain 25,31,37 2.410.560 460.501.668 Miscellaneous JUMLAH PENDAPATAN (BEBAN) LAIN-LAIN (245.082.703) (509.333.387 TOTAL OTHER INCOME (EXPENSES) LABA SEBELUM PAJAK TBA8725027 228107434 PROFIT BECOME INCOME TAX MANFAAT (BEBAN) PAJAK PENGHASILAN INCOME TAX (EXPENSES) BENEFIT Kini 2t14c - - Current Tangguhan 2t,14e,14d - - Deferred JUMLAH MANFAAT (BEBAN) TOTAL INCOME TAX PAJAK PENGHASILAN : : (EXPENSES) BENEFIT LABA TAHUN BERJALAN T348725.027 928107434 PROFIT FOR THE YEAR PENGHASILAN (RUGI) OTHER COMPREHENSIVE KOMPREHENSIF LAIN INCOME (EXPENSES) Pengukuran kembali Remeasurement of imbalan pasca kerja - - post-employment benefits Pajak penghasilan yang berkaitan dengan Income tax relating to components komponen lainnya pendapatan komprehensif - Pa of other comprehensive income LABA KOMPREHENSIF 'COMPREHENSIVE INCOME TAHUN BERJALAN 1.348.725.027 G28.107.435 CURRENT YEAR Laba bersih yang dapat diatribusikan kepada: Net income attributable to: Pemilik entitas induk. 1.848.709.824 928.107.434 Owners of tho parent Kepentingan non pengendali 15.203 - Non controlling interests 1.848.725.027 S28107434 Jumlah penghasilan komprehensif Total comprehensive income tahun berjalan yang dapat diatribusikan kepada: for the year attributable to: Pemilik entitas induk 1.348.709.824 928.107.435 Owners of the parent Kepentingan non pengendali 15.203 2 Non controlling interests 348.725.027 928107435 LABA PER SAHAM 2w,32 0,30 0,39 EARNING PER SHARE Jakarta, 30 April/ April 30, 2025 Lx Eranciscus Xaverius Yoshua Raintiung Marcella Angelin Direktur Utama President Director Direktur Director Catatan atas laporan keuangan merupakan bagian yang tidak terpisahkan dari laporan keuangan Head Office : Kawasan Industri Pulogadung 31 Rawa Gelam V, Blok L, Kav.1l-13 Gedung Etana 3FI, Jakarta - 13930 The accompanying notes from an integral part of these financial statements Contact Us: (021 3seesno www.ubcindonesia.com
Names mentioned 2 people and organisations named in the text · linked when the evidence is strong
Extraction attempts how the parser did, and what it refused
Nothing structured was extracted from this document — the attempts below say why.
No extraction attempted yet.